Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/70976| Title: | Botulinum toxin for upper limb cerebral palsy in children : evidence of efficacy and rationale for its use |
| Authors: | Azzopardi, Ernest A. Boyce, Dean E. |
| Keywords: | Botulinum toxin -- Therapeutic use Botulinum toxin -- Side effects Cerebral palsy Pain -- Treatment |
| Issue Date: | 2019 |
| Publisher: | British Association of Plastic Reconstructive & Aesthetic Surgeons |
| Citation: | Azzopardi, E. A., & Boyce, D. E. (2019). Botulinum toxin for upper limb cerebral palsy in children : evidence of efficacy and rationale for its use. British Association of Plastic Reconstructive & Aesthetic Surgeons Winter Conference. Monaco: Royal College of Surgeons in England. |
| Abstract: | Background: Cerebral Palsy (CP) affects 0.2% of live births worldwide. Its resultant motor spasticity contributes to reduced upper limb function and a significantly reduced quality of life. Intramuscular injection of Botulinum Toxin A (BoNT-A) for upper limb CP is gaining popularity. However, its use for paediatric patients remains off-license and off-label. The administering surgeon therefore requires an up to date, evidence-based rationale to justify its use in an NHS setting, and advise on best-practice. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/70976 |
| Appears in Collections: | Scholarly Works - FacM&SAna |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Botulinum Toxin for .pdf | 84.71 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.